INO — INOVIO PHARMACEUTICALS INC

Ownership history in GMT CAPITAL CORP  ·  5 quarters on record

This page tracks every 13F SEC filing in which GMT CAPITAL CORP reported a position in INOVIO PHARMACEUTICALS INC (INO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.03% (2024 Q3)
Avg. % of fund
0.02%
First filed
2024 Q3
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 126,119 — 0% 0.01% $295K $2.34
2025 Q2 UNCHANGED 126,119 — 0% 0.01% $257K $2.04
2025 Q1 REDUCED 126,119 -2 -0.0% 0.01% $206K $1.63
2024 Q4 UNCHANGED 126,121 — 0% 0.01% $231K $1.83
2024 Q3 INITIATED 126,121 — — 0.03% $729K $5.78
% of Fund (quarterly)    INO price (monthly, adj. close)

Other funds also holding INO

As of 2025 Q4 — sorted by position size

ADAR1 Capital Management, LLC 0.19% Green Alpha Advisors, LLC 3Y 0.11% Persistent Asset Partners Ltd 0.11% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.07% 683 Capital Management, LLC 3Y 7Y 0.02% ADAR1 Capital Management, LLC 0.01% XTX Topco Ltd 3Y 0.01% ADAGE CAPITAL PARTNERS GP, L.L.C. 3Y 7Y 0.01% BRIDGEWAY CAPITAL MANAGEMENT, LLC 3Y 7Y 0.01% Covestor Ltd 3Y 0.01%
← Back to GMT CAPITAL CORP Holdings